HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,355,489 | -68.9% | 35,484 | -70.6% | 0.00% | -69.2% |
| Q2 2023 | $4,360,249 | +1308.5% | 120,883 | +1391.3% | 0.01% | +1200.0% |
| Q1 2023 | $309,568 | -92.5% | 8,106 | -91.6% | 0.00% | -94.4% |
| Q4 2020 | $4,118,000 | -51.2% | 96,415 | -70.0% | 0.02% | -45.5% |
| Q3 2020 | $8,434,000 | +162.8% | 320,946 | +168.1% | 0.03% | +106.2% |
| Q2 2020 | $3,209,000 | +113.2% | 119,693 | +43.0% | 0.02% | +60.0% |
| Q1 2020 | $1,505,000 | -81.7% | 83,683 | -82.0% | 0.01% | -63.0% |
| Q4 2019 | $8,246,000 | -26.9% | 465,054 | -36.1% | 0.03% | -35.7% |
| Q3 2019 | $11,287,000 | +10.8% | 727,733 | +22.7% | 0.04% | +13.5% |
| Q2 2019 | $10,188,000 | -18.3% | 593,058 | -23.4% | 0.04% | -21.3% |
| Q1 2019 | $12,471,000 | -34.3% | 774,578 | -40.3% | 0.05% | -44.0% |
| Q4 2018 | $18,982,000 | -11.3% | 1,297,446 | +10.1% | 0.08% | +7.7% |
| Q3 2018 | $21,405,000 | +85.3% | 1,178,052 | +72.1% | 0.08% | +62.5% |
| Q2 2018 | $11,549,000 | +89.7% | 684,603 | +120.3% | 0.05% | +71.4% |
| Q1 2018 | $6,089,000 | – | 310,798 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |